You are here

Innovation Driven by Real World Data: Where Do We Start?

On December 13, 2018, AmCham Belgium’s Innovative Healthcare Committee organized the second in a series of healthcare-specific events, focused on the practical opportunities for using Real World Data in innovation.

The Innovative Healthcare Committee – a cross-industry platform where proposals contributing to a qualitative and sustainable healthcare ecosystem for tomorrow’s patients are nurtured – published a reflection paper Real World Data – the Key to Securing an Innovative Belgian Healthcare Landscape during a first successful event in April 2018.

Real World Data (RWD) can be defined as patients’ health and lifestyle data obtained through real world settings, i.e. the daily life of the patient, rather than the data collected from clinical trials.

Whereas the first event focused on the reflection paper, the challenges and opportunities of RWD uptake in the Belgian healthcare sector, this second event looked into the practical realization of innovation driven by RWD. The event welcomed three speakers, each presenting their views on the next steps that are necessary to unleash the potential of RWD in Belgium.

Etienne Maeriën, eHealth Advisor in the Cabinet of the Minister of Public Health, opened the event by giving an update on the Federal Government’s data for better health initiative, calling on industry to join the movement. This initiative is focused on Findable, Accessible, Interoperable and Reusable (FAIR) data.

The power of data in healthcare was explained by Joan Van Loon, Belux Enterprise Business Unit Leader Public, Life Sciences, Telco & Utilities at IBM. He mentioned the “price of not knowing”. Currently, companies are faced with a $2 trillion waste in the healthcare industry, generated by unnecessary tests, failed clinical trials, fraud, abuse, etc. By using RWD, these unnecessary costs could be avoided in the future. According to IBM, “existing systems of care, wellness, and support must come together with technology, data, and expertise to help people live healthier and more productive lives.”

Catherine Reed, Principal Research Scientist at Eli Lilly, presented the ROADMAP project: “Real world Outcomes across the Alzheimer’s Disease spectrum for better care: Multi-modal data Access Platform”. This private-public partnership was setup to explore the usability of all available data sources in the decision-making process linked to Alzheimer’s disease.

Eager to know more? Take a look at the video to hear Olivia Natens, Country Director Belux at Medtronic and Chair of the Innovative Healthcare Committee, explaining the importance and value of Real World Data for the innovative healthcare sector in Belgium:

Check out the photos of the event! 

If you would like to learn more about the Innovative Healthcare Committee, please contact Johanna Vijverman at the Secretariat.